GeneDx announces AI-powered gene ranker

March 17, 2025
GeneDx's Multiscore tool to be showcased at the American College of Medical Genetics and Genomics (ACMG) annual meeting.

GeneDx announced Multiscore, an advanced AI-powered decision support tool. Multiscore is embedded into GeneDx’s interpretation platform as a decision support tool to help clinical geneticists focus on the most relevant genes during their clinical analysis. 

GeneDx will present the AI-powered decision support tool at ACMG, in a session: Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in 10,000 Exomes and Genomes.

Through the combination of GeneDx’s proprietary dataset, publicly available data, and the power of AI, Multiscore prioritizes genes in exome and genome sequences by ranking them based on alignment with a patient’s clinical presentation.

By leveraging the accumulated insights within GeneDx’s database of 750,000 clinical exome and genome sequences and over six million phenotypic datapoints, Multiscore offers a continuously updated knowledge base and ensures the most current gene-disease associations are incorporated into the interpretation process regularly.

GeneDx release